许培扬博客分享 http://blog.sciencenet.cn/u/xupeiyang 跟踪国际前沿 服务国内科研

博文

精准医学:胃癌个体化治疗信息分析与知识发现

已有 2203 次阅读 2015-5-18 07:41 |个人分类:精准医学|系统分类:科研笔记

 

检索分析系统

 http://www.pubmedplus.cn/

http://www.gopubmed.org/web/gopubmed/1?WEB013yge0vato9pyI9I1I00h001000d1002020000100100000011100040111

研究论文175篇分布如下

publications over timepublications over time

 

字段:年份 趋势图
记录数
占%
 01.2014     23 13.143%
 02.2013     25 14.286%
 03.2012     20 11.429%
 04.2011     21 12.000%
 05.2010     16 9.143%
 06.2009     8 4.571%
 07.2008     6 3.429%
 08.2007     7 4.000%
 09.2006     9 5.143%
字段:期刊
记录数
占%
 01.world j gastroenterol     9 5.143%
 02.ann surg oncol     7 4.000%
 04.hepatogastroenterology     4 2.286%
 05.int j radiat oncol biol phys     4 2.286%
 06.chirurg     3 1.714%
 07.discov med     3 1.714%
 08.dtsch med wochenschr     3 1.714%
 09.gan to kagaku ryoho     3 1.714%
字段:中国大陆外机构
记录数
占%
 01.庆应义塾大学     7 4.000%
 02.德国慕尼黑技术大学医院     6 3.429%
 03.延世大学     4 2.286%
 04.延世大学医学院     4 2.286%
 05.德克萨斯大学     4 2.286%
 06.美国德州大学md安德森癌症中心     4 2.286%
 07.三星医疗中心     3 1.714%
 08.成均馆大学     3 1.714%
 09.日本庆应义塾大学医学部     3 1.714%
 10.汉城国立大学     3 1.714%
查看更多
字段:中国大陆单位
记录数
占%
 01.上海交通大学医学院附属瑞金医院     2 1.143%
 02.中山大学肿瘤防治中心     2 1.143%
 03.北京大学肿瘤医院     2 1.143%
 04.哈尔滨医科大学附属第三医院(肿瘤医院)     2 1.143%
 05.复旦大学附属中山医院     2 1.143%
 06.浙江大学校本部     2 1.143%
 07.上海交通大学医学院第六人民医院     1 0.571%
查看更多
字段:中国作者
记录数
占%
 01.北京大学肿瘤医院.季加孚     2 1.143%
 02.北京大学肿瘤医院.张连海     2 1.143%
 03.哈尔滨医科大学附属第三医院(肿瘤医院).薛英威     2 1.143%
 04.上海交通大学医学院第六人民医院.吴彬     1 0.571%
 05.上海交通大学医学院第六人民医院.张强     1 0.571%
 06.上海交通大学医学院第六人民医院.张谊     1 0.571%
 07.上海交通大学医学院第六人民医院.朱金水     1 0.571%
 08.上海交通大学医学院第六人民医院.沈炜明     1 0.571%
 09.上海交通大学医学院附属仁济医院.倪醒之     1 0.571%
 10.上海交通大学医学院附属仁济医院.刘华     1 0.571%
查看更多
字段:作者缩写
记录数
占%
 01.Kitagawa Y     6 3.429%
 02.Roukos DH     5 2.857%
 03.Feith M     4 2.286%
 04.Kitajima M     4 2.286%
 05.Siewert JR     4 2.286%
 06.Baba H     3 1.714%
 07.Ji JF     3 1.714%
 08.Kubota T     3 1.714%
 09.Lee J     3 1.714%
 10.Li H     3 1.714%
查看更多
字段:文献主题词 趋势图
记录数
占%
 01.stomach neoplasms     110 62.857%
 02.neoplasm staging     33 18.857%
 03.prognosis     30 17.143%
 04.individualized medicine     28 16.000%
 05.gastrectomy     27 15.429%
 06.treatment outcome     26 14.857%
 07.combined modality therapy     20 11.429%
 08.esophageal neoplasms     19 10.857%
 09.lymphatic metastasis     19 10.857%
 10.adenocarcinoma     18 10.286%
查看更多
字段:副主题词搭配 趋势图
记录数
占%
 01.Stomach Neoplasms/pathology     39 22.286%
 02.Stomach Neoplasms/surgery     24 13.714%
 04.Stomach Neoplasms/mortality     22 12.571%
 05.Stomach Neoplasms/surgery*     22 12.571%
 06.Stomach Neoplasms/therapy*     19 10.857%
 07.Stomach Neoplasms/genetics*     16 9.143%
 08.Stomach Neoplasms/pathology*     16 9.143%
 10.Stomach Neoplasms/genetics     13 7.429%
查看更多
字段:国家 分布图
记录数
占%
 01.日本     34 19.429%
 02.中国大陆     28 16.000%
 03.美国     23 13.143%
 04.德国     22 12.571%
 05.韩国     15 8.571%
 06.意大利     5 2.857%
 07.加拿大     4 2.286%
 08.英国     4 2.286%
 09.中国香港     3 1.714%
 10.荷兰     3 1.714%
查看更多
字段:城市
记录数
占%
 01.韩国首尔     12 6.857%
 02.日本东京     10 5.714%
 03.德国慕尼黑     7 4.000%
 04.中国上海     6 3.429%
 05.美国休斯敦     5 2.857%
 06.中国北京     4 2.286%
 07.浙江杭州     4 2.286%
 08.中国香港     3 1.714%
 09.日本石川     3 1.714%
 10.美国安德森(安德森癌症中心)     3 1.714%
查看更多
字段:中国省份 分布图
记录数
占%
 01.上海     6 3.429%
 02.浙江省     5 2.857%
 03.北京     4 2.286%
 04.香港     3 1.714%
 05.山东省     2 1.143%
 06.广东省     2 1.143%
 07.黑龙江省     2 1.143%
 08.天津     1 0.571%
 09.江苏省     1 0.571%
 10.河北省     1 0.571%
查看更多
字段:药物
记录数
占%
 01.tumor markers, biological     29 16.571%
 02.neoplasm proteins     19 10.857%
 03.protein kinases     19 10.857%
 04.protein-tyrosine kinases     17 9.714%
 05.receptor protein-tyrosine kinases     17 9.714%
 06.oncogene proteins     16 9.143%
 07.proto-oncogene proteins     16 9.143%
 08.receptors, growth factor     15 8.571%
 09.receptors, peptide     15 8.571%
 10.曲妥单抗     15 8.571%
查看更多
字段:Substance
记录数
占%
 01.antineoplastic agents     18 10.286%
 02.tumor markers, biological     12 6.857%
 03.fluorouracil     8 4.571%
 04.antibodies, monoclonal     7 4.000%
 05.antibodies, monoclonal, humanized     6 3.429%
 06.cisplatin     6 3.429%
 07.receptor, erbb-2     6 3.429%
 08.erbb2 protein, human     5 2.857%
 09.trastuzumab     5 2.857%
 10.receptor protein-tyrosine kinases     4 2.286%
查看更多
字段:中药
记录数
占%
 01.dang shen     1 0.571%
 02.云芝     1 0.571%
 03.麦芽     1 0.571%
字段:疾病
记录数
占%
 01.肿瘤     171 97.714%
 02.消化系统疾病     155 88.571%
 03.消化系统肿瘤     154 88.000%
 04.胃癌     148 84.571%
 05.胃肠疾病     148 84.571%
 06.胃肠癌     148 84.571%
 07.胃疾病     137 78.286%
 08.癌,肿瘤     49 28.000%
 09.肿瘤转移     45 25.714%
 10.癌形成过程     37 21.143%
查看更多
字段:症状
记录数
占%
 01.肿瘤转移     43 24.571%
 02.癌形成过程     37 21.143%
 03.淋巴转移     26 14.857%
 04.复发     17 9.714%
 05.死亡     16 9.143%
 06.局部癌复发     9 5.143%
 07.疾病恶化     8 4.571%
 08.肿瘤侵袭     8 4.571%
 09.carcinogenesis     7 4.000%
 10.手术后并发症     6 3.429%
查看更多
字段:治疗方法
记录数
占%
 01.药物疗法     71 40.571%
 02.外科手术     64 36.571%
 03.消化系统外科手术     53 30.286%
 04.胃切除术     43 24.571%
 05.个性化医学     42 24.000%
 06.淋巴结切除术     34 19.429%
 07.综合疗法     33 18.857%
 08.内窥镜检查     27 15.429%
 09.临床方案     24 13.714%
 10.活组织检查     23 13.143%
查看更多
字段:科室
记录数
占%
 01.department of surgery     30 17.143%
 02.department of gastroenterology     5 2.857%
 03.department of general surgery     5 2.857%
 04.department of internal medicine     5 2.857%
 05.department of medicine     5 2.857%
 06.school of medicine     5 2.857%
 07.department of gastroenterological surgery     4 2.286%
 08.department of pathology     4 2.286%
 09.department of gastrointestinal surgery     3 1.714%
 10.department of medical oncology     3 1.714%
查看更多
字段:物种
记录数
占%
 01.animals     157 89.714%
 02.chordata     157 89.714%
 03.eukaryota     157 89.714%
 04.vertebrates     157 89.714%
 05.catarrhini     156 89.143%
 06.hominidae     156 89.143%
 07.mammals     156 89.143%
 08.haplorhini     155 88.571%
 09.humans     155 88.571%
 10.primates     155 88.571%
查看更多
字段:解剖
记录数
占%
 01.     55 31.429%
 02.淋巴     37 21.143%
 03.淋巴结     37 21.143%
 04.胃肠道     33 18.857%
 05.消化系统     30 17.143%
 06.组织     27 15.429%
 07.上胃肠道     25 14.286%
 08.     19 10.857%
 09.食管     17 9.714%
 10.细胞     16 9.143%
查看更多
字段:食品
记录数
占%
 01.phosphorus     32 18.286%
 02.protein     7 4.000%
 03.tyrosine     5 2.857%
 04.fish     3 1.714%
 05.fluoride     2 1.143%
 06.iron     2 1.143%
 07.spirits     2 1.143%
 08.食品     2 1.143%
 09.glucose     1 0.571%
 10.potassium     1 0.571%
查看更多
字段:作者与主题词
记录数
占%
 01.上海交通大学医学院第六人民医院.吴彬研究antineoplastic agents/therapeutic use     1 0.571%
 02.上海交通大学医学院第六人民医院.吴彬研究drug resistance, neoplasm     1 0.571%
 03.上海交通大学医学院第六人民医院.吴彬研究drug screening assays, antitumor/methods     1 0.571%
 04.上海交通大学医学院第六人民医院.吴彬研究patient selection     1 0.571%
 05.上海交通大学医学院第六人民医院.吴彬研究stomach neoplasms/drug therapy     1 0.571%
 06.上海交通大学医学院第六人民医院.吴彬研究tetrazolium salts     1 0.571%
 07.上海交通大学医学院第六人民医院.吴彬研究thiazoles     1 0.571%
 08.上海交通大学医学院第六人民医院.张强研究antineoplastic agents/therapeutic use     1 0.571%
 09.上海交通大学医学院第六人民医院.张强研究drug resistance, neoplasm     1 0.571%
 10.上海交通大学医学院第六人民医院.张强研究drug screening assays, antitumor/methods     1 0.571%
查看更多
字段:主题词与主题词
记录数
占%
 01.antineoplastic combined chemotherapy protocols/therapeutic use与stomach neoplasms/drug therapy     10 5.714%
 02.gastrectomy/methods与stomach neoplasms/surgery     6 3.429%
 03.antineoplastic agents/therapeutic use与stomach neoplasms/drug therapy     4 2.286%
 04.esophageal neoplasms/pathology与stomach neoplasms/pathology    4 2.286%
 05.stomach neoplasms/drug therapy与stomach neoplasms/genetics    4 2.286%
 06.stomach neoplasms/genetics与tumor markers, biological/genetics    4 2.286%
 07.adenocarcinoma/diagnosis与stomach neoplasms/diagnosis     3 1.714%
 08.carcinoma, hepatocellular/radiotherapy与liver neoplasms/radiotherapy     3 1.714%
 09.carcinoma, hepatocellular/radiotherapy与radiotherapy planning, computer-assisted/methods     3 1.714%
 10.esophageal neoplasms/pathology与sentinel lymph node biopsy     3 1.714%
查看更多
字段:单位与单位
记录数
占%
 01.温州医科大学附属第二医院(育英儿童医院)与温州医科大学校本部合作     1 

0.571%

 

 

 

 

 

 

 

知识发现结果如下  

http://arrowsmith.psych.uic.edu/cgi-bin/arrowsmith_uic/edit_b.cgi

A-query: stomach cancer
C-query: individualized therapy

The B-list contains title words and phrases (terms) that appeared in both the A and the C literature. 175 articles appeared in both literatures and were not included in the process of computing the B-list but can be viewed here. The results of this search are saved under id # 6088 and can be accessed from the start page after you leave this session. There are 1292 terms on the current B-list (415 are predicted to be relevant), which is shown ranked according to predicted relevance. The list can be further trimmed down using the filters listed in the left margin.

To assess whether there appears to be a biologically significant relationship between the AB and BC literatures for specific B-terms, please select one or more B-terms and then click the button to view the corresponding AB and BC literatures. Use Ctrl to select multiple B-terms.

 

job id # 6088 started Sun May 17 18:37:25 2015
Max_citations: 50000
Stoplist: /var/www/arrowsmith_uic/data/stopwords_pubmed
Ngram_max: 3
A_query_raw: stomach cancer Sun May 17 18:37:33 2015

A query = stomach cancer started Sun May 17 18:37:34 2015
A query resulted in 50000 titles
C_query_raw: individualized therapy Sun May 17 18:37:46 2015

C: individualized therapy 23879

A: stomach cancer 92576

AC: ( stomach cancer ) AND ( individualized therapy ) 175

C_query_raw: individualized therapy Sun May 17 18:37:51 2015

C: individualized therapy 23879

A: stomach cancer 92576

AC: ( stomach cancer ) AND ( individualized therapy ) 175

C query = individualized therapy started Sun May 17 18:37:51 2015
C query resulted in 23879 titles
A AND C query resulted in 175 titles
26071 B-terms ready on Sun May 17 18:40:57 2015

Sem_filter:
Genes & Molecular Sequences, and Gene & Protein Names
1292 B-terms left after filter executed Sun May 17 18:43:19 2015

B-list on Sun May 17 18:48:18 2015
1 brca2
2 adiponectin
3 brca1
4 promoter polymorphism
5 cyp2c19
6 cyp2d6
7 akt
8 vegf
9 mthfr
10 nat2
11 k ras
12 single nucleotide polymorphism
13 mtor
14 fdg
15 stat3
16 cox-2
17 her-2 neu
18 toll receptor
19 tp53
20 braf
21 pi3k
22 her2
23 gstp1
24 herg
25 pten
26 her-2
27 cancer gene expression
28 ugt1a1
29 notch1
30 dpyd
31 dihydropyrimidine dehydrogenase
32 promotor polymorphism
33 cyp2a6
34 microsatellite
35 cytokine gene
36 ppargamma
37 dota
38 mdr1
39 multiple endocrine neoplasia
40 microrna
41 promoter methylation
42 tnm
43 gene promoter polymorphism
44 ercc1
45 dihydropyrimidine dehydrogenase gene
46 statin
47 cd133
48 gene promoter
49 beta catenin
50 cyclin e

 

 

1990年,研究者发现了一种直接与遗传性乳腺癌有关的基因,命名为
乳腺癌1号基因,英文简称BRCA1。1994年,又发现另外一种与乳腺癌有关的基因,称为BRCA2。
实际上,BRCA1/2是两种具有抑制恶性肿瘤发生的基因,在调节人体细胞的复制、遗传物质DNA损伤修复、细胞的正常生长方面有重要作用。拥有这个基因突变的家族倾向于具有高乳腺癌发生率[1] ,通常发生在较年轻时,病人的两侧乳房都确癌,且同时患有卵巢癌。 http://baike.baidu.com/link?url=W46_fTcwMThKkGn9FWr_NatvlFPNvK1agyhGdxIH_lgRlpDlBgJ5geMCHNafPapa01qdgPwtGc9doIW7PSkm2q
AB literature

 

B-term

 

BC literature

 

stomach cancer brca2individualized therapy
1: [Genetic counselling in male carriers of BRCA1 and BRCA2 gene mutations]. 2012
Add to clipboard

2: A case of familial breast cancer with double heterozygosity for BRCA1 and BRCA2 genes. 2012
Add to clipboard

3: BRCA1 and BRCA2 mutations among familial breast cancer patients from Costa Rica. 2011
Add to clipboard

4: Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations. 2011
Add to clipboard

5: Cancer prevalence in 129 breast-ovarian cancer families tested for BRCA1 and BRCA2 mutations. 2010
Add to clipboard

6: The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified. 2008
Add to clipboard

7: Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations. 2006
Add to clipboard

8: Spontaneous and irradiation-induced tumor susceptibility in BRCA2 germline mutant mice and cooperative effects with a p53 germline mutation. 2006
Add to clipboard

9: BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian. 2005
Add to clipboard

10: Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. 2004
Add to clipboard

11: Cancer variation associated with the position of the mutation in the BRCA2 gene. 2004
Add to clipboard

12: No germline mutations in the histone acetyltransferase gene EP300 in BRCA1 and BRCA2 negative families with breast cancer and gastric, pancreatic, or colorectal cancer. 2004
Add to clipboard

13: Risk of cancer at sites other than the breast in Swedish families eligible for BRCA1 or BRCA2 mutation testing. 2004
Add to clipboard

14: A high frequency of BRCA2 gene mutations in Polish families with ovarian and stomach cancer. 2003
Add to clipboard

15: The effect of a single BRCA2 mutation on cancer in Iceland. 2002
Add to clipboard

16:BRCA2 gene mutations in families with aggregations of breast and stomach cancers. 2002
Add to clipboard

17: Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. 2001
Add to clipboard

18: Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium. 1999
Add to clipboard

19: Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers. 1999
Add to clipboard

20: A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals. 1996
Add to clipboard

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1: In Brief: BRCA1 and BRCA2. 2013
Add to clipboard

2: BRCA1 and BRCA2 mutations and breast cancer. 2011
Add to clipboard

3: Contralateral breast cancer in BRCA1/BRCA2 mutation carriers: the story of the other side. 2009
Add to clipboard

4: Targeting Fanconi anemia/BRCA2 pathway defects in cancer: the significance of preclinical pharmacogenomic models. 2007
Add to clipboard

5: [Hereditary breast and ovarian cancer: primary and secondary prevention for BRCA1 and BRCA2 mutation carriers] 2007
Add to clipboard

6: Bilateral risk-reducing oophorectomy in BRCA1 and BRCA2 mutation carriers. 2006
Add to clipboard

 

 

 

 

 

 http://arrowsmith.psych.uic.edu/cgi-bin/arrowsmith_uic/show_sentences.cgi

 

 

 

 

 



https://wap.sciencenet.cn/blog-280034-890937.html

上一篇:科学网外有网
下一篇:父母糖尿病后代眼疾病风险信息分析与知识发现
收藏 IP: 114.111.167.*| 热度|

0

该博文允许注册用户评论 请点击登录 评论 (0 个评论)

数据加载中...
扫一扫,分享此博文

Archiver|手机版|科学网 ( 京ICP备07017567号-12 )

GMT+8, 2024-4-20 11:18

Powered by ScienceNet.cn

Copyright © 2007- 中国科学报社

返回顶部